RT Journal Article
SR Electronic
T1 Trends in diagnostic tests ordered for children: a retrospective analysis of 2 million laboratory test requests in Oxfordshire, UK from 2005 to 2019
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.12.15.22283423
DO 10.1101/2022.12.15.22283423
A1 Thomas, Elizabeth T
A1 Withrow, Diana R
A1 Shine, Brian
A1 Gill, Peter J
A1 Perera, Rafael
A1 Heneghan, Carl
YR 2022
UL http://medrxiv.org/content/early/2022/12/19/2022.12.15.22283423.abstract
AB Summary Diagnostic tests play an essential role in children’s health. Previous work has shown variation in the use of diagnostic tests for adults. However, comparatively little is known about the use of tests in children. We aimed to analyze temporal trends in laboratory testing for children aged 0 to 15 from 2005 to 2019 in Oxfordshire, United Kingdom.Methods For this retrospective analysis, we used data from the Oxfordshire University Hospital NHS Trust laboratories. Using joinpoint regression models, we estimated annual percentage changes (APC) in test use. Temporal changes in age-adjusted rates in test use were calculated overall and stratified by healthcare setting, sex and age.Findings Between 2005 and 2019, overall test use increased in children (APC 1.6%, 95 confidence interval -0.8% to 4.1%). Increases were highest in females, in those aged 11-15 years and the outpatient setting. The most frequently requested tests were full blood count, urea and electrolytes, liver function test, C-reactive protein and calcium magnesium phosphate. The test with the greatest increase in use was Vitamin D, which increased on average by 27% per year. Other tests that showed a significant temporal increase included parathyroid hormone, iron studies, folate, vitamin B12 levels, glucose, HbA1c, IgA, coeliac, creatine kinase, thyroid function tests and IgG/IgM. Test changes were not uniformly distributed across all settings and age groups.Interpretation The increase in test use may be the result of a combination of factors, including changes to the health service resulting in an increased volume of presentations and referrals, shifts in workforce composition towards less experienced clinicians, increased parental anxiety and expectation of tests and/or increased awareness and changing prevalence of disease. Further research is needed to quantify whether test use is warranted and to compare trends in Oxfordshire with other settings.Funding No funding was obtained for this study.Evidence before this study We searched PubMed using the terms “diagnostic test” “child” and “variation” from inception until 7 November 2022 to identify studies related to diagnostic test use in children. Previous studies have demonstrated substantial variation in the use of diagnostic tests across primary and secondary care in the UK. However, most of the literature on diagnostic testing focused on adults. Population-based studies of UK primary care identified that test use had increased by 9% annually from 2000 to 2015. Tests with the highest increase were knee MRIs which increased by 69% per year, followed by vitamin D tests and brain MRI. Tests subject to the greatest practice variation included drug monitoring, urine microalbumin and pelvic CTs. However, these studies did not specifically analyse data on test use in children. A few studies on children examined variation in the use of tests for specific conditions, such as community-acquired pneumonia, orbital cellulitis, fever or diabetes. No studies have quantified test use across all settings or examined temporal trends in test use in children.Added value of this study To our knowledge, this is the first population-based study to estimate long-term trends in childhood test use. We collected data on laboratory tests that were analysed at the Oxfordshire University Hospital NHS Trust laboratories for children aged below 16 between 2005 and 2019 and evaluated average annual percentage change and annual percentage change in test use using joinpoint regression. We found that test use increased by 2% per year overall, with the highest increases in the outpatient setting and for females aged 11-15. Vitamin D tests experienced the greatest overall increase during the study period.Implications of all the available evidence Changes in test use may suggest potentially inappropriate testing, especially for Vitamin D and C reactive protein. It also suggests an increase in disease awareness and prevalence as well as changes in the healthcare workforce and service provision. A comparison between testing rates and the corresponding test results must be made to better understand whether increased test use is warranted. The observed trends in this study should also be compared with other settings to determine their generalisability. We encourage clinicians to become aware of their test-ordering practices and consider the individual and systemic implications of testing in children.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://doi.org/10.17605/OSF.IO/KE6DM Funding StatementThis study did not receive any funding Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Oxford Clinical Trials and Research Governance committee waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll R code used for data management, analysis and creating the figures is archived online at https://github.com/elizabethtthomas/paediatric-testing-oxfordshire. https://github.com/elizabethtthomas/paediatric-testing-oxfordshire